Testing the V-Lap system for heart failure monitoring
Part of Heart & circulation clinical trials.
This trial tests a new device called V-Lap that is placed in the heart to monitor pressure. It may help doctors better manage heart failure and reduce hospital stays. Researchers want to see if it works well in people with mild to moderate heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with heart failure for at least 6 months.
- You have had at least one heart failure-related hospital stay or urgent visit in the last year.
- Your BNP or NT-proBNP levels are above a certain threshold, adjusted for your weight.
- You are on the recommended medications for heart failure and your doses have been stable for at least a month.
- You or your caregiver can use a smartphone or tablet for a health app.
- You are at least 22 years old and not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
This study tests whether a small wireless sensor can safely measure and track pressure in the left upper heart chamber in people with advanced chronic heart failure. It may help the care team better understand pressure changes that are linked to fluid buildup and symptoms, alongside your usual heart medicines.
This trial tests a device that treats and monitors heart failure. It may help people with chronic heart failure and reduced heart function who still have symptoms despite standard treatments.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This trial tests a home monitoring system called Cardiosignal to help manage heart failure after an emergency room visit. It may help doctors adjust your treatments to keep you healthier at home.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.